ETON stock forecast
Our latest prediction for Eton Pharmaceuticals Inc's stock price was made on the Sept. 26, 2022 when the stock price was at 2.04$.
In the short term (2weeks), ETON's stock price should underperform the market by -1.27%. During that period the price should oscillate between -12.51% and +5.87%.
In the medium term (3months), ETON's stock price should outperform the market by 13.31%. During that period the price should oscillate between -33.79% and +48.44%.
Get email alertsCreate a solid portfolio with ETON
About Eton Pharmaceuticals Inc
eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.
At the moment the company generates 22M USD in revenues.
On its last earning announcement, the company reported a loss of -0.35$ per share.
The book value per share is 1.09$
Three months stock forecastSept. 26, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
22M | 54.56% | -10M | -49.66% | -11M | -0.35 | - | - | 25M | 1.09 | - | - | - |